Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 5.86p
   
  • Change Today:
      0.000p
  • 52 Week High: 9.80
  • 52 Week Low: 4.88
  • Currency: UK Pounds
  • Shares Issued: 201.37m
  • Volume: 189,590
  • Market Cap: £11.80m
  • RiskGrade: 510

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-23 Interim n/a (5.21) (2.36)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 0.10 (4.10) (3.45)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (4.79) (3.53)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (17.73) (9.46)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (57.86) (24.28)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (20.09) (8.76)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 n/a (11.00) (4.63)p n/a n/a n/a 3.00p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Synairgen Market Data

Currency UK Pounds
Share Price 5.86p
Change Today 0.000p
% Change 0.00 %
52 Week High 9.80
52 Week Low 4.88
Volume 189,590
Shares Issued 201.37m
Market Cap £11.80m
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.22% above the market average63.22% above the market average63.22% above the market average63.22% above the market average63.22% above the market average
72.55% above the sector average72.55% above the sector average72.55% above the sector average72.55% above the sector average72.55% above the sector average
Price Trend
68% below the market average68% below the market average68% below the market average68% below the market average68% below the market average
3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
15:45 1,307 @ 6.50p
15:45 31,936 @ 6.23p
15:22 2,200 @ 5.91p
14:34 975 @ 5.91p
13:02 5,000 @ 6.21p

Synairgen Key Personnel

CEO Richard J Marsden

Top of Page